Shore Capital Reaffirms "Buy" Rating for Kainos Group (LON:KNOS)
Shore Capital restated a “buy” rating on shares of Kainos Group in a research report on Wednesday.
Source link
Similar Posts
India’s Agriculture Export Policy to Go Under Review – Equitypandit
December 25, 2024December 25, 2024 The six-year-old Agricultural Export Policy (AEP) is set to undergo a review to address shifting global market trends and diversify India’s export portfolio. The revamp aims to boost the global competitiveness of Indian agricultural products, align with international standards, and promote value-added exports. It…
Mastek Q4 PAT declines 14% YoY while revenue rises nearly 12%. Co declares Rs 16 dividend
IT company Mastek reported its results for the fourth quarter ended March 2025 on Friday, where its consolidated net profit declined 14.1% year-on-year (YoY) to Rs 81.1 crore, while revenue from operations grew a healthy 16.6% YoY. The company’s board also proposed a final dividend of Rs 16 per share for its shareholders. The net…
Edgar Bronfman submits roughly $4.3 billion rival bid for Paramount Global By Reuters
By Dawn Chmielewski (Reuters) -Veteran media executive Edgar Bronfman Jr. on Monday submitted a roughly $4.3 billion bid in which it would acquire National Amusements, the company that holds a controlling interest in entertainment giant Paramount Global , a person familiar with the matter told Reuters. The competing offer for the home of Paramount Pictures,…
Wockhardt shares bounce back 4% after two-day slump
Wockhardt shares rebounded 4% to Rs 1,388 in Friday’s trading session, recovering after falling 5% each day for two straight sessions. Earlier in the week, on December 1, 2025, the stock had surged 19% following a major regulatory development: the US Food and Drug Administration (FDA) formally accepted Wockhardt’s New Drug Application (NDA) for Zaynich,…
